Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
Liver disease activity, indicated by cT1, increases the risk of developing ALS, independent of metabolic syndrome, liver fat, or fibrosis. ANN NEUROL 2025;97:270-280.
Authors
- Xinyue Yu (ORCID: https://orcid.org/0000-0001-5356-5177)
- Dongsheng Fan (ORCID: https://orcid.org/0000-0002-3129-9821)
- Lihuai Du (ORCID: https://orcid.org/0000-0001-6600-9970)
- Yaojia Li
- Yinuo Chen (ORCID: https://orcid.org/0000-0003-2130-5965)
- Chunyang Pang (ORCID: https://orcid.org/0000-0002-3382-6664)
- Jiali Xie
- Binbin Deng (ORCID: https://orcid.org/0000-0002-4058-0738)
- Lingfei Gao
- Can Cui
- Wen Cao (ORCID: https://orcid.org/0000-0003-1518-4706)
- Luyi Zhu
- Huan Yu
- Junwei Zhang
Institutions
- Wenzhou University (CN)
- Peking University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Karolinska Institutet (SE)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
- Shanghai East Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1002/ana.27115
- Citations
- 5
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province